We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Jefferies Financial Group
JEF
$13.1B
| $49.1M | 0.11% |
1,915,149
-40,286
| -2% | -$1.19M |
|
227
Invesco
IVZ
$13.9B
| $49M | 0.11% |
3,116,267
+519,902
| +20% | +$9.84M |
|
228
Huntsman Corp
HUN
$1.77B
| $48.9M | 0.11% |
1,738,365
+1,281,161
| +280% | +$43.3M |
|
229
Humana
HUM
$46.2B
| $48.2M | 0.11% |
102,932
+19,925
| +24% | +$8.87M |
|
230
Travel + Leisure Co
TNL
$4.7B
| $48.1M | 0.11% |
1,261,767
+572,057
| +83% | +$28.2M |
|
231
United Parcel Service
UPS
$88.9B
| $48M | 0.11% |
268,915
-23,909
| -8% | -$4.36M |
|
232
Prologis
PLD
$133B
| $47.8M | 0.11% |
413,789
-130,225
| -24% | -$18M |
|
233
Kimberly-Clark
KMB
$36.5B
| $47.7M | 0.11% |
356,014
+62,146
| +21% | +$8.19M |
|
234
Netflix
NFLX
$309B
| $47.5M | 0.11% |
2,776,740
+1,729,430
| +165% | +$38.3M |
|
235
Dick's Sporting Goods
DKS
$18.7B
| $47.4M | 0.11% |
636,689
+387,139
| +155% | +$34.4M |
|
236
Western Union
WU
$2.21B
| $47.4M | 0.11% |
2,908,148
+1,708,759
| +142% | +$30.1M |
|
|
MRSH
237
Marsh
MRSH
$91.5B
| $47.3M | 0.11% |
308,089
-23,413
| -7% | -$3.75M |
|
|
QVCGA
238
DELISTED
QVC Group Inc Series A
QVCGA
| $47.2M | 0.11% |
335,078
+198,581
| +145% | +$38.6M |
|
|
PDCE
239
DELISTED
PDC Energy, Inc.
PDCE
| $47.1M | 0.11% |
763,964
+348,724
| +84% | +$25.3M |
|
240
Sibanye-Stillwater
SBSW
$7.53B
| $46.9M | 0.11% |
4,708,636
+614,611
| +15% | +$8.03M |
|
241
Nordson
NDSN
$17.3B
| $46.6M | 0.11% |
233,741
-35,249
| -13% | -$7.52M |
|
242
IQVIA
IQV
$39.3B
| $46.3M | 0.1% |
215,927
-104,726
| -33% | -$22.7M |
|
243
Salesforce
CRM
$158B
| $46M | 0.1% |
283,619
+78,825
| +38% | +$13.9M |
|
244
Vale
VALE
$62.6B
| $45.8M | 0.1% |
3,132,350
-6,010,044
| -66% | -$103M |
|
245
Williams-Sonoma
WSM
$29.6B
| $45.7M | 0.1% |
843,912
+42,632
| +5% | +$2.76M |
|
246
NIO
NIO
$11.9B
| $45.5M | 0.1% |
2,095,824
-121,415
| -5% | -$2.23M |
|
247
American Electric Power
AEP
$68.4B
| $45.3M | 0.1% |
473,834
-123,624
| -21% | -$12.3M |
|
248
Albertsons Companies
ACI
$5.83B
| $44.7M | 0.1% |
1,675,008
+407,696
| +32% | +$12.5M |
|
249
Acuity Brands
AYI
$10.8B
| $44.5M | 0.1% |
288,953
-25,069
| -8% | -$4.25M |
|
250
Prudential Financial
PRU
$41.8B
| $44.3M | 0.1% |
470,209
-45,683
| -9% | -$4.84M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.